hyperlactataemia

English

Noun

hyperlactataemia

Misspelling of hyperlactatemia.
- 2015 July 4, Mazvita Naome Mberi et al., “Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004–2012: a cohort study”, in BMC Health Services Research‎, volume 15, DOI:10.1186/s12913-015-0912-2:
  Table 4 ART related adverse events experienced by patients and proportions that had adverse events in patients that were LTFU versus those still in care, Tshepang Pharmacovigilance cohort, 2004-2012 *Others include anaemia, various dermatological adverse events, Central nervous system adverse events, diarrhoea and vomiting, lipid abnormalities and hepatititis In the multivariable Cox regression model, the risk factors that were independently associated ( p 200 cells/ml (aHR = 3.81, 95 % CI: 1.85-7.85), having a history of an ART related adverse event prior to outcome (aHR = 0.61, 95 % CI: 0.38-0.99), having a last known viral load that was detectable (aHR = 3.60, 95 % CI: 1.98-6.52), and having a last known WHO clinical stage three or four (aHR = 2.00, 95 % CI: 1.22-3.27), (Table 5 ).

单词	hyperlactataemia
释义	hyperlactataemia English Noun hyperlactataemia Misspelling of hyperlactatemia. 2015 July 4, Mazvita Naome Mberi et al., “Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004–2012: a cohort study”, in BMC Health Services Research‎, volume 15, DOI:10.1186/s12913-015-0912-2: Table 4 ART related adverse events experienced by patients and proportions that had adverse events in patients that were LTFU versus those still in care, Tshepang Pharmacovigilance cohort, 2004-2012 *Others include anaemia, various dermatological adverse events, Central nervous system adverse events, diarrhoea and vomiting, lipid abnormalities and hepatititis In the multivariable Cox regression model, the risk factors that were independently associated ( p 200 cells/ml (aHR = 3.81, 95 % CI: 1.85-7.85), having a history of an ART related adverse event prior to outcome (aHR = 0.61, 95 % CI: 0.38-0.99), having a last known viral load that was detectable (aHR = 3.60, 95 % CI: 1.98-6.52), and having a last known WHO clinical stage three or four (aHR = 2.00, 95 % CI: 1.22-3.27), (Table 5 ).
随便看	mancipaverant mancipaveras mancipaverat mancipaveratis mancipavere mancipaverim mancipaverimus mancipaverint mancipaveris mancipaverit mancipaveritis mancipavero mancipaverunt mancipavi mancipavimus mancipavisse mancipavissem mancipavissemus mancipavissent mancipavisses mancipavisset mancipavissetis mancipavisti mancipavistis mancipavit